Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL160785 | 0.84 | — | — | |
| SCHEMBL973837 | 0.81 | TSHR (0.38) | TSHR | |
| SCHEMBL7003465 | 0.79 | TSHR (0.62) | TSHR | |
| SCHEMBL27470512 | 0.78 | TSHR (0.35) | TSHR | |
| SCHEMBL27475759 | 0.76 | CA1 (0.35) | TSHR | |
| SCHEMBL6776319 | 0.76 | TSHR (0.36) | TSHR | |
| SCHEMBL3127292 | 0.76 | TSHR (0.64) | TSHR | |
| SCHEMBL7299928 | 0.74 | LYPLA1 (0.40) | TSHR | |
| SCHEMBL10616231 | 0.74 | ALDH1A1 (0.33) | TSHR | |
| SCHEMBL1167599 | 0.73 | ENPP2 (0.35) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5616711-A | REACTING BUTENE DERIVATIVE TO AN AMIDE DERIVATIVE; USEFUL AS INTERMEDIATES FOR PRODUCING ANTIULCER DRUGS | FUJIREBIO INC. (JP) | 1997-04-01 | — | — | US | claimed |
| EP-0582304-A2 | Methods of producing amino butene derivatives | FUJIREBIO Inc. (JP) | 1994-02-09 | — | — | EP | claimed |
| US-5616711-A | REACTING BUTENE DERIVATIVE TO AN AMIDE DERIVATIVE; USEFUL AS INTERMEDIATES FOR PRODUCING ANTIULCER DRUGS | FUJIREBIO INC. (JP) | 1997-04-01 | — | — | US | disclosed |
| EP-0582304-A2 | Methods of producing amino butene derivatives | FUJIREBIO Inc. (JP) | 1994-02-09 | — | — | EP | disclosed |